Lewes, DE -- (SBWIRE) -- 08/31/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Affymax, Inc. (OTCMKTS: AFFY), United Online, Inc. (NASDAQ:UNTD),
Keryx Biopharmaceuticals (NASDAQ:KERX), Compuware Corporation (NASDAQ:CPWR).
Affymax, Inc. (OTCMKTS: AFFY) decreased -8.77% and closed at $1.56 on a traded volume of 1.26 million shares, in comparison to 1.44 million shares of average trading volume. So far this year, the stock is down over -91.59%.
The company has a total market capitalization of $58.48 million and its total outstanding shares are 37.49 million.
Will AFFY Get Buyers Even After The Recent Rally? Find Out Here
Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
United Online, Inc. (NASDAQ:UNTD) plunged -3.68% and closed at $7.85 on a traded volume 1.24 million shares, whereas its average trading volume is 975.678 shares. In the last three months, the stock is up 15.44%. The Intra-day range for the stock is $7.84 and $8.21.
Will UNTD Get Buyers Even After The Recent Rally? Find Out Here
United Online, Inc., through its subsidiaries, provides consumer products and services over the Internet primarily in the United States, Canada, and Europe. The company operates in three segments: FTD, Content and Media, and Communications.
Keryx Biopharmaceuticals (NASDAQ:KERX) dropped -1.95% and closed at $8.53. So far in three months, the stock is up 4.53%. The 52-week range for the stock is $2.00 and $9.98 and during the previous trading session the stock touched its highest price at $8.76. Its introductory price for the day was $8.69, with the overall traded volume of 1.24 million shares.
Will KERX Get Buyers Even After The Recent Rally? Find Out Here
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Compuware Corporation (NASDAQ:CPWR) after opening its trade at the price of $10.83, dropped -1.20% to close at $10.67 for the day. The stock moved on a traded volume of 1.21 million shares, in comparison to 2.37 million shares of average trading volume.
The 52-week range for the stock is $7.97 and $12.74 and during the previous trading session the stock touched its highest price at $10.86.
Will CPWR Get Buyers Even After The Recent Rally? Find Out Here
Compuware Corporation provides services, software, and practices for information technology (IT) organizations worldwide.
About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/